Get started
Author

M. E. Cianfrocca

Observed names: M Cianfrocca, M E Cianfrocca, M. Cianfrocca, M.E. Cianfrocca, ME Cianfrocca
Institutions: Siriraj Hospital, St. Marianna University School of Medicine, University of New Mexico, Centre Hospitalier Universitaire de Besançon, Nagoya City University Hospital, Gangnam Severance Hospital, Yonsei University Health System
Observed institutions: Northwestern University, University of Southern California, Fox Chase Cancer Center, Virginia Mason Medical Center, Mayo Clinic, Siriraj Hospital, Montefiore Medical Center, Orlando Health, University of California, Los Angeles, St. Marianna University School of Medicine, University of New Mexico, University of Pittsburgh, Loyola University Chicago, Allegheny General Hospital, Massachusetts General Hospital, Centre Hospitalier Universitaire de Besançon, Magee-Womens Hospital, GlaxoSmithKline (United States), Nagoya City University Hospital, Dana-Farber Cancer Institute, Gangnam Severance Hospital, Yonsei University Health System, NRG Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, UCLA Jonsson Comprehensive Cancer Center, McGill University
OpenAlex ID: A5111582813
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours
2006 · M E Cianfrocca, K A Kimmel, et al. · British Journal of Cancer · 184
PDF
New Molecular Classifications of Breast Cancer
2009 · M. Cianfrocca, W. Gradishar · CA A Cancer Journal for Clinicians · 109
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer
2006 · M.E. Cianfrocca, W.J. Gradishar · Breast Diseases A Year Book Quarterly · 46
A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients
2005 · Q. Chu, L. Goldstein, et al. · Journal of Clinical Oncology · 26
Treatment of Kaposi's sarcoma.
2001 · J H Von Roenn, M Cianfrocca · PubMed · 10
A phase I trial of pegylated liposomal anthracycline and lapatinib (L) combination in the treatment of metastatic breast cancer (MBC): First evaluation of an anthracycline and lapatinib combination in the treatment of MBC
2007 · M. E. Cianfrocca, S. T. Rosen, et al. · Journal of Clinical Oncology · 7
A Phase I Trial of a Pegylated Liposomal Anthracycline (Doxil TM) and Lapatinib Combination in the Treatment of Metastatic Breast Cancer: Dose-Escalation Results of an Anthracycline and Lapatinib Combination Trial.
2009 · M. Cianfrocca, V. Kaklamani, et al. · Cancer Research · 4
Histological differentiation of skin toxicity between cetuximab, erlotinib and panitumumab (single ErbB1) and lapatinib (dual ErbB1/2) epidermal growth factor receptor inhibitors
2009 · M. Newman, P. Gerami, et al. · Journal of Clinical Oncology · 4
Epidemic Kaposi's sarcoma.
1998 · M Cianfrocca, J H Roenn · PubMed · 4
Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+ Breast Cancer.
2009 · V. Kaklamani, R. Uthe, et al. · Cancer Research · 3
Phase III study of paclitaxel (Pac) versus pegylated liposomal doxorubicin (PLD) for the treatment of advanced human immunodeficiency virus (HIV)-associated Kaposi's sarcoma (KS): An Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium
2007 · J. H. Von Roenn, S. Lee, et al. · Journal of Clinical Oncology · 3
Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy
2016 · PA Ganz, RS Cecchini, et al. · Cancer Research · 2
AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors.
2011 · J. F. Deeken, M. A. Rudek, et al. · Journal of Clinical Oncology · 1
Screening mammography is associated with earlier stage disease and greater eligibility for breast conservation in women aged 4o and older with breast cancer
2002 · G.M Freedman, P Anderson, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Abstract P2-11-08: Stomatitis in patients treated with first-line everolimus (EVE) plus letrozole (LET): Results from BOLERO-4 trial
2017 · C Villanueva, K Tsugawa, et al. · Cancer Research
Phase I study of lapatinib (GW572016) in combination with letrozole in cancer patients
2005 · Quincy Chu, Eric K. Rowinsky, et al. · ePrints Soton (University of Southampton)
147 Phase I pharmacokinetic (PK) and safety study of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2) in patients with solid tumors
2004 · M.E. Cianfrocca, J. Gallo, et al. · European Journal of Cancer Supplements
Works count: 17
Citation count: 404
H-index: 6
I10-index: 5
Year
Topic
Type